Union Budget 2022 | We were expecting some incentives for Pharma R&D: Kiran Mazumdar Shaw
The Hindu
Public investment was very low in this critical area of research and innovation, says Biocon chief
The industry was expecting some incentives for Pharma R&D in the budget as public investment was very low in this critical area of research and innovation, said Kiran Mazumdar Shaw, Chairperson, Biocon & Biocon Biologics.
“We were expecting some incentives for Pharma R&D in the Budget as public investment is very low in this critical area of research and innovation, which are key for spurring exponential economic growth,’‘ she reacted.
The finance minister has assured the government’s support for R&D expenditure in sunrise areas such as drones, AI, genomics, space and clean energy etc, she said adding, “We will need to see the fine print if there is anything on pharma.’‘
According to BACL, the biophilic-inspired business park will offer smart workspaces within a vibrant public realm. The project’s most exceptional and breathtaking attribute lies in the Urban Forest, a lush oasis in the centre of the development. This green space will serve as a focal point, seamlessly blending indoor and outdoor spaces throughout the area. The upcoming metro station in Airport City will provide seamless connectivity to the business park from the northern side, ensuring convenient accessibility.